Skip to main content
Clinical Trials/NL-OMON54555
NL-OMON54555
Recruiting
Phase 3

Antibiotic prophylaxis for children with recurrent respiratory infections: towards evidence-based guidelines - Approach study

HagaZiekenhuis0 sites158 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
HagaZiekenhuis
Enrollment
158
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria: \- Presenting to one of the participating clinics; \-
  • Age 6 months \- 10 years; \- Suffering from recurrent respiratory tract
  • infections (RTIs); \- Informed consent from parent(s)/caregiver(s) with legal
  • custody. For age\-specific definitions of recurrent RTIs, we took cut\-offs as
  • defined by the Dutch Society of Pediatric except for children aged 5\-10 years
  • in whom we used the same definition as younger children (2\-5 years). This means
  • yearly at least 11 and 8 parental\-reported upper RTIs including, but not
  • limited to, otitis media for children aged \<2 and 2\-10 years respectively.
  • Recurrent lower RTIs (i.e. pneumonia, bronchopneumonia or acute bronchitis) are

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • \- Current prophylactic antibiotic use or prophylactic antibiotic use during the
  • previous month;
  • \- Underlying immune deficiency other than for IgA or IgG subclasses;
  • \- Congenital abnormalities (including cleft palate, neuromuscular, cardial and
  • syndromal disorders, hematologic disorders;
  • \- Suffering from chronic respiratory disease, such as cystic fibrosis (CF),
  • primary ciliary dyskinesia (PCD) or anatomical abnormalities;
  • \- Children who only suffer from recurrent acute otitis media or chronic

Outcomes

Primary Outcomes

Not specified

Similar Trials